Paper Details

  1. Home
  2. Paper Details

Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical Studies.

Author: BrealeyClive, GillenMichael, LauDavid, LeesePhilip, MartinPaul, MillsonDavid, OliverStuart, SurryDominic, SweenyDavid

Clinical Trial, Phase IThe first stage of clinical trials in humans. Evaluates the safety, tolerability, and pharmacokinetics of a new drug/treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Fostamatinib is a prodrug that induces CYP2C8, an enzyme responsible for metabolizing various drugs, including pioglitazone. This study investigated the effect of fostamatinib on the pharmacokinetics of pioglitazone. Coadministration of fostamatinib and pioglitazone was associated with lower pioglitazone and hydroxy pioglitazone levels, suggesting that fostamatinib may decrease the efficacy of pioglitazone. However, no significant safety concerns were observed.
Paper Details　
Original Abstract of the Article :
Fostamatinib is a prodrug that undergoes gastrointestinal tract dephosphorylation to form the active metabolite, R406. Here we report its cytochrome P450-inducing potential. In vitro, R406 3 and 10 μM induced CYP2C8 to levels representing 53% and 75%, respectively, of the level achieved by the posit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/cpdd.243

データ提供：米国国立医学図書館（NLM）

Fostamatinib's Impact on Pioglitazone Pharmacokinetics

This research investigates the potential interaction between fostamatinib, a drug used to treat certain types of cancer, and pioglitazone, a medication used to manage type 2 diabetes. The researchers explored the effects of fostamatinib on the pharmacokinetics of pioglitazone, examining how the two drugs interact within the body. It's like observing the complex interplay of different species in a desert ecosystem, understanding how their interactions influence the environment and each other's survival.

Navigating Drug Interactions

The study found that fostamatinib can induce the enzyme CYP2C8, which is involved in the metabolism of pioglitazone. This interaction can lead to lower levels of pioglitazone in the body, potentially affecting its effectiveness. It's like introducing a new species into a delicate desert ecosystem, potentially disrupting the balance and causing unintended consequences. This research emphasizes the importance of careful consideration when prescribing medications, particularly those that can interact with each other.

Understanding Drug Interactions for Safe and Effective Treatment

This research highlights the importance of understanding drug interactions to ensure safe and effective treatment. It emphasizes the need for careful monitoring and adjustments to medication regimens when patients are taking multiple drugs. It's like having a skilled guide to navigate the complex landscape of drug interactions, ensuring that our medications work effectively and safely. This research encourages healthcare professionals to prioritize patient safety and optimize medication regimens to achieve the best possible outcomes.

Dr. Camel's Conclusion

This study underscores the importance of understanding drug interactions, a critical aspect of safe and effective medication management. It's a reminder that our bodies are complex systems, and medications can interact with each other in unexpected ways. Let's continue to research and understand these interactions, striving to optimize medication regimens and ensure the well-being of our patients.

Date :
  1. Date Completed 2018-01-16
  2. Date Revised 2021-12-04
Further Info :

Pubmed ID

27163495

DOI: Digital Object Identifier

10.1002/cpdd.243

Related Literature

Article Analysis
・Effects of fostamatinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.